← Leaderboards
Andrew J.w. Huang
University Of Minnesota Twin Cities
$2,475,709
Attributed
$3,308,313
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $713.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,308,313 · 4
By mechanism
R01$2,575,779 · 2
R21$437,047 · 1
R03$295,487 · 1
Top collaborators
- Qin Liu2 shared
- Lixing W Reneker2 shared
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- John D Lipscomb$11,827,480
Others in their field
Top investigators on “Monitor”
- Jeffrey P Krischer · University Of South Florida$631,818,376
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$476,087,269
- Bambra Strokes · Ppd Development Lp$461,655,950
- David Heimbrook · Leidos Biomedical Research, Inc.$367,240,481
- Lawrence Corey · Fred Hutchinson Cancer Center$302,301,802
Research focus
MonitorOcular SurfacePreventAnimal ModelProductionEpithelial CellsPainMediatingCorneaReportingPathogenesisNovel TherapeuticsAmyloid FormationDeletion MutagenesisDepositionAmyloid Fibril FormationBinding (Molecular Function)Corneal StromaElementsCongo RedCollagenCorneal DystrophyAmyloidCoculture Techniques
Grant awards (10)
Neural mechanism underlying corneal injuries by ammonia$514,851
R01 · FY2025 · EY · contact PI
Neural mechanism underlying corneal injuries by ammonia$713,311
R01 · FY2024 · EY · contact PI
Targeting Fibroblast Growth Factor Signaling as a New Therapeutic Strategy for Meibomian Gland Dysfunction$189,756
R21 · FY2021 · EY
Targeting Fibroblast Growth Factor Signaling as a New Therapeutic Strategy for Meibomian Gland Dysfunction$247,291
R21 · FY2020 · EY
ABNORMAL BIGH3 AGGREGATIONS IN CORNEAL DYSTROPHIES$325,037
R01 · FY2011 · EY · contact PI
ABNORMAL BIGH3 AGGREGATIONS IN CORNEAL DYSTROPHIES$338,580
R01 · FY2010 · EY · contact PI
ABNORMAL BIGH3 AGGREGATIONS IN CORNEAL DYSTROPHIES$342,000
R01 · FY2009 · EY · contact PI
ABNORMAL BIGH3 AGGREGATIONS IN CORNEAL DYSTROPHIES$342,000
R01 · FY2008 · EY · contact PI
Suppression of Myocilin by siRNA$145,987
R03 · FY2006 · EY · contact PI
Suppression of Myocilin by siRNA$149,500
R03 · FY2005 · EY